UBS Group’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-467,641
Closed -$28.2M 8412
2016
Q2
$28.2M Sell
467,641
-107,911
-19% -$6.12M 0.02% 740
2016
Q1
$26.5M Sell
575,552
-250,624
-30% -$9.09M 0.02% 724
2015
Q4
$39.9M Buy
826,176
+128,003
+18% +$5.52M 0.03% 585
2015
Q3
$29.7M Buy
698,173
+131,207
+23% +$6.5M 0.02% 680
2015
Q2
$32.4M Sell
566,966
-70,540
-11% -$4.35M 0.02% 712
2015
Q1
$41.1M Buy
637,506
+34,968
+6% +$2M 0.03% 585
2014
Q4
$30M Buy
+602,538
New +$31.3M 0.02% 755

Other funds holding MDVN

UBS Group's MDVN Position: Q3 2016 in Review

UBS Group sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 467,641 shares — an estimated $28.2M sold.

UBS Group first reported a position in MDVN in Q4 2014 and held it in 7 quarters. The position peaked at $41.1M in Q1 2015. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • UBS Group reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • UBS Group sold 467,641 MEDIVATION, INC. shares in Q3 2016, an estimated $28.2M.
  • UBS Group first reported a position in MEDIVATION, INC. in Q4 2014 and held it in 7 quarters.
  • UBS Group's MEDIVATION, INC. position peaked at $41.1M in Q1 2015.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.